YOLFTbeta
Innocare Optoelectronics Corp.

Innocare Optoelectronics Corp.

6861 · TW · Healthcare / Medical Devices

193.50TWD+13.50 (+7.50%)

Price History

Full chart

Market Stats

Previous Close180.00
Open183.00
Day Range183.00 – 198.00
52-Week Range55.43 – 486.78
Volume1.01M
Market Cap12.31B
P/E (TTM)46.11
Forward P/E0.00
EPS6.42
Dividend Yield0.68%
Beta2.31
50-Day Avg217.17
200-Day Avg208.66

About

InnoCare Optoelectronics Corporation engages in the design, development, manufacture, and sale of optical instruments and medical devices. It also offers X-ray flat panel detectors sensors for healthcare, veterinary, security, and industrial applications in Taiwan and internationally. It offers thin film transistors and scintillators, and other medical products, as well as accessories, including power and ethernet cables, charger sets, and batteries. InnoCare Optoelectronics Corporation was founded in 2019 and is headquartered in Tainan City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOEric Lee
  • Employees0
  • HeadquartersNo. 2, Southern Taiwan Science Park, Tainan City, Taiwan, 74144, Taiwan
  • Websitehttps://www.innocare-x.com

Leadership

  • Eric LeePresident
  • Ivy ChengFinance & Accounting Manager

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue432.56M2.34B1.94B1.89B1.84B1.99B2.29B
Growth (%)-+439.88%-16.90%-2.79%-2.62%+8.30%+15.29%
Cost of Revenue224.76M1.88B1.41B1.30B1.33B1.44B1.73B
Gross Profit207.80M458.29M525.92M583.21M502.67M552.28M559.90M
Gross Margin48.04%19.62%27.10%30.91%27.36%27.76%24.41%
Operating Expense120.91M211.23M292.07M335.94M471.50M518.86M424.20M
Operating Income86.90M247.06M233.85M247.27M31.17M33.42M135.70M
Operating Margin20.09%10.58%12.05%13.11%1.70%1.68%5.92%
EBITDA94.95M205.17M172.60M156.06M95.73M280.53M213.10M
EBITDA Margin21.95%8.79%8.89%8.27%5.21%14.10%9.29%
Net Income82.79M166.03M198.52M198.72M116.66M152.94M159.51M
Net Income Margin19.14%7.11%10.23%10.53%6.35%7.69%6.95%
R&D75.31M168.90M239.67M248.44M228.28M275.04M218.94M
R&D as % of Total Revenue17.41%7.23%12.35%13.17%12.43%13.82%9.54%
Interest Expense192.00K698.00K803.00K5.28M7.34M2.92M2.01M
Interest Expense % of Total Revenue0.04%0.03%0.04%0.28%0.40%0.15%0.09%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-2.03B1.70B2.00B2.27B2.37B2.58B
Total Liabilities251.00K1.63B1.07B1.18B983.71M989.00M1.12B
Total Equity-397.58M636.68M816.62M1.28B1.38B1.46B
Cash-749.02M459.45M577.37M671.66M774.98M869.07M
Total Debt-38.30M39.89M459.49M190.66M174.05M135.32M
Net Debt--710.71M-419.56M-117.88M-481.00M-600.93M-733.75M

Cash Flow

Currency: TWD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow440.78M-126.25M-253.25M109.20M234.93M281.61M
Investing Cash Flow-209.01M-187.47M-23.25M-74.52M-52.03M-79.20M
Financing Cash Flow-77.51M30.38M391.55M76.86M-87.06M-112.80M
Capital Expenditure205.95M67.60M62.66M61.80M90.98M41.44M
Free Cash Flow234.83M-193.85M-315.91M47.40M143.96M240.17M
Dividends Paid--38.48M51.20M44.29M74.76M
FCF to OCF53.28%153.54%124.74%43.41%61.28%85.28%
Dividend Paid to FCF---12.18%108.02%30.77%31.13%

Earnings

Report DateMay 8, 2023Aug 10, 2023
EPS Estimate0.220.28
EPS Actual0.170.30
Surprise-22.73%7.14%
TimingAfter-hoursPre-market

Key Statistics & Ratios

Market Cap12.31B
Enterprise Value10.60B
Trailing P/E46.11
Forward P/E0.00
Price / Sales4.47
Price / Book7.29
EPS6.42
Book Value37.45
Revenue (TTM)2.75B
Gross Profit (TTM)713.09M
EBITDA304.44M
Profit Margin9.78%
Operating Margin12.56%
Return on Equity18.46%
Return on Assets5.68%
Shares Outstanding41.60M
Shares Float19.56M
Beta2.31
Dividend Yield0.68%
Dividend Rate2.00
Payout Ratio31.11%

Dividends

20261×
2.00Jun 15, 2026
20251×
1.80Jun 5, 2025
20241×
1.10Jun 12, 2024
20231×
1.30Jun 9, 2023
20221×
1.10Jun 10, 2022